 First-mover in the red-hot psychedelic medicine field Pioneering the use of psychedelics to treat mental health and addiction disorders Strong portfolio of research into psychedelics complements ongoing clinical trials What Braxia Scientific does: Braxia Scientific Corp CSE:BRAX, formerly Champignon Brands Inc CSE:SHRM OTCMKTS:SHRMF is quickly emerging as a leader in the burgeoning field of psychedelic medicine. The company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder PTSD, as well as substance and alcohol use disorders. 